29 reports

Six months after their heart attack, about half the patients in the study had become non-adherent to at least one of their medicines.

  • Dementia
  • Healthcare
  • Pharmaceutical
  • Salicylic Acid
  • United States

One year ago, we were able to confirm that oxygen therapy does not appear to reduce the risk of dying up to one year after the heart attack.

  • Cancer
  • Dementia
  • Sweden
  • Karolinska Institutet Holding
  • Takeda Pharmaceutical Company Limited

IN 2010, A YEAR BEFORE ACTOS' PATENT EXPIRATION, A STUDY WAS PUBLISHED DEMONSTRATING A SIMILAR RISK OF HEART ATTACK AND ACUTE HEART FAILURE BETWEEN ACTOS AND AVANDIA, AND THE FDA BEGAN CONDUCTING A REVIEW OF ACTOS DUE TO CONCERNS ABOUT THE INCREASED RISK OF BLADDER CANCER IN P

  • Dementia
  • Allergan plc
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Novartis AG

A number of deaths have been unexplained, with a few related to heart attacks and fatal heart disruptions.

  • Dementia
  • Biogen Idec Inc.
  • Novartis AG
  • Roche Group
  • Sanofi S.A.

They are of three types: simple partial seizure, complex partial seizure, and secondary generalized attack.

  • Dementia
  • Biogen Idec Inc.
  • Merck Serono S.A.
  • Novartis AG
  • Pfizer Inc.

The company offers products for cancer, stroke and heart attack.

  • Dementia
  • Stroke
  • Therapy
  • Company
  • Product Initiative

The programs will utilize the facilities at one or more of the University of Texas' campuses.

  • Dementia
  • United States
  • Company
  • Deals & Alliance
  • Premier Biomedical, Inc.
  • Jan 16, 2018: Anavex Life Sciences Reports Potential Normalization of Hypertension with ANAVEX2-73 Published in The Journal of Clinical Hypertension

Uncontrolled high blood pressure can lead to heart disease, kidney damage or stroke.

  • Dementia
  • Psychotic Disorder
  • United States
  • Company
  • Anavex Life Sciences Corp.

The study was funded by the British Heart Foundation.

  • Clinical Trial
  • Dementia
  • Pharmaceutical
  • United States
  • Company

The report reveals that sigma-## receptor (S##R) agonists play an important role in the prevention, delay or reduction of heart disease.

  • Dementia
  • Pharmaceutical
  • United States
  • Product Initiative
  • Anavex Life Sciences Corp.

The company offers products for cancer, stroke and heart attack.

  • Dementia
  • Pharmaceutical
  • Stroke
  • Therapy
  • Athersys, Inc.

" We may be able to treat the JUN ##, 2016: NEW ALZHEIMER' S STUDY AIMED AT PREVENTING OR DELAYING SYMPTOMS disease using interventions before it becomes advanced, much like you treat high cholesterol to mitigate the risk of heart attacks. "

  • Dementia
  • United States
  • Company Operations
  • Product Initiative
  • Eisai Co., Ltd.
  • IBUDILAST - DRUG PROFILE

NO HEART ATTACKS OR STROKES), AND NO DEATHS RELATED TO MN-## (IBUDILAST) TREATMENT, AS DETERMINED BY AN INDEPENDENT MEDICAL MONITOR.

  • Blood Disease
  • Dementia
  • Hospital
  • Therapy
  • MediciNova, Inc.

IN AFRICA, CVDS ARE ESTIMATED TO KILL ## PEOPLE EVERY DAY; AFRICA ALSO SEES ## STROKES AND ## HEART ATTACKS OCCURRING DAILY.

  • Dementia
  • North America
  • United States
  • World
  • Market Size

Twenty-nine of the proteinswere also elevated in patients who suffered " unplanned" heart attacks.

  • Dementia
  • Diagnostics
  • Mental Health
  • Pathology
  • SomaLogic, Inc.

If all goes well, they hope to use this technique to treat patients who have suffered a heart attack.

  • Dementia
  • Pharmaceutical
  • Therapy
  • United States
  • Gladstone Institutes

There were no infections, no cancers, no cardiovascular events (i. e. no heart attacks or strokes), and no deaths related to MN-## (ibudilast) treatment.

  • Antimalarials
  • Clinical Trial
  • Dementia
  • Therapy
  • MediciNova, Inc.

May ##, 2018: Researchers find gut microbiome plays an important role in atherosclerosis Researchers at Western University and Lawson Health Research Institute have shown a novel relationship between the intestinal microbiome and atherosclerosis, one of the major causes of heart

  • Dementia
  • Healthcare
  • Psychotic Disorder
  • Therapy
  • Canada
  • WILL BE GIVEN TO SUBJECTS IN THE OPEN-LABEL EXTENSION FOR AN ADDITIONAL 6 MONTHS.

THE STUDY WILL EVALUATE THE EFFECT OF BB## TO PRESERVE MYOCARDIAL (HEART) TISSUE AND FUNCTION FOLLOWING MYOCARDIAL INFARCTION (HEART ATTACK).

  • Dementia
  • Regenerative Medicine
  • United States
  • Product Initiative
  • Anavex Life Sciences Corp.
  • ANAVEX-371 - DRUG PROFILE

These target patients have significant residual risk in major adverse coronary events (MACE) such as heart attack, unstable angina, stroke, revascularization and death, despite standard of care therapy such as statins.

  • Dementia
  • Monoclonal Antibody
  • United States
  • Company
  • Product Initiative

ACUTE CORONARY SYNDROME IS A TERM USED TO DESCRIBE SITUATIONS OR EVENTS, INCLUDING HEART ATTACK, WHERE THERE IS AN ABRUPT REDUCTION OF BLOOD FLOW TO THE HEART THROUGH THE CORONARY ARTERIES.

  • Dementia
  • Hospital
  • United States
  • Product Initiative
  • GlaxoSmithKline plc
  • ibudilast - Drug Profile

There were no opportunistic infections, no cancers, no cardiovascular events (i. e. no heart attacks or strokes), and no deaths related to MN-## (ibudilast) treatment, as determined by an Independent Medical Monitor.

  • Dementia
  • Pharmaceutical
  • United States
  • Product Initiative
  • MediciNova, Inc.
  • IBUDILAST - DRUG PROFILE

NO HEART ATTACKS OR STROKES), AND NO DEATHS RELATED TO MN-## (IBUDILAST) TREATMENT, AS DETERMINED BY AN INDEPENDENT MEDICAL MONITOR.

  • Cell Therapy
  • Dementia
  • United States
  • Product Initiative
  • Anavex Life Sciences Corp.

Ariosa and Premaitha will cooperate on their patent invalidity attacks.

  • Clinical Trial
  • Dementia
  • Prostate Cancer
  • United States
  • AutoGenomics, Inc.

IMPORTANTLY, IRL## DID NOT AFFECT HEART RATE, BLOOD PRESSURE OR ELECTROCARDIOGRAPHY (ECG).

  • Dementia
  • Therapy
  • United States
  • Product Initiative
  • Eisai Co., Ltd.
  • ALZHEIMER'S DISEASE - PIPELINE BY DIFFUSION PHARMACEUTICALS INC
  • ALZHEIMER'S DISEASE - PIPELINE BY DENALI THERAPEUTICS INC

The company offers products for cancer, stroke and heart attack.

  • Dementia
  • Pharmaceutical
  • Therapy
  • Company
  • Product Initiative

The IRIS trial included ##, ## patients who recently had a stroke or heart attack, insulin resistance and who did not have diabetes.

  • Dementia
  • Mental Health
  • United States
  • Company Operations
  • Suven Life Sciences Ltd
  • JUN 14, 2016: NEW ALZHEIMERS STUDY AIMED AT PREVENTING OR DELAYING SYMPTOMS

" We may be able to treat the disease using interventions before it becomes advanced, much like you treat high cholesterol to mitigate the risk of heart attacks. "

  • Clinical Trial
  • Dementia
  • Drug Development
  • Pharmaceutical
  • World
  • PARKINSON'S DISEASE - PIPELINE BY DERMAXON LLC,

The company provides products for cancer, stroke, and heart attack.

  • Dementia
  • Psychotic Disorder
  • United States
  • Company
  • Product Initiative